Fresenius Medical Care AGFME.DE

XetraHealthcareMedical Care Facilities
Price (close)
€39.80
Market cap
€10.6B
P/E
10.8x
Revenue (FY)
€19.6B
Net income
€978.4M
Dividend yield
3.74%
1-year total return
-5.2%
Net margin
5.0%
Revenue growth
1.5%
Debt / equity
0.55x

What Fresenius Medical Care AG does.

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Revenue and profit, by fiscal year.

Fiscal year2022202320242025
Revenue€19.4B€19.5B€19.3B€19.6B
Net income€673.4M€499.0M€537.9M€978.4M
Free cash flow€1.4B€1.9B€1.7B€1.8B

More on FME.DE.

Figures from Fresenius Medical Care AG's annual reports (ESEF, via filings.xbrl.org) and Yahoo Finance, standardised automatically; prices are end-of-day closes. Not financial advice.